An assessment of the factors affecting the commercialization of cell-based therapeutics: a systematic review protocol

An assessment of the factors affecting the commercialization of cell-based therapeutics: a systematic review protocol

Abstract Background Cellular-based therapies represent a platform technology within the rapidly expanding field of regenerative medicine and are distinct from conventional therapeutics—offering a unique approach to managing what were once considered untreatable diseases. Despite a significant increa...

Full description

Bibliographic Details
Main Authors: David Pettitt, Zeeshaan Arshad, Benjamin Davies, James Smith, Anna French, Doug Cole, Kim Bure, Sue Dopson, David DiGiusto, Jeff Karp, Brock Reeve, Richard Barker, Georg Holländer, David Brindley
Format: Article
Language:English
Published: BMC 2017-06-01
Series:Systematic Reviews
Subjects:
Cell-based therapies
Translational medicine
Commercialization
Clinical adoption
Online Access:http://link.springer.com/article/10.1186/s13643-017-0517-4

Internet

http://link.springer.com/article/10.1186/s13643-017-0517-4

Similar Items